Company Filing History:
4 out of 917 
3 out of 1,863 
2 out of 2,343 
Years Active: 2014-2021
Title: Imre Noth: Innovator in Pulmonary Fibrosis Research
Introduction
Imre Noth is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of pulmonary fibrosis research. With a total of 4 patents, Noth has made strides in developing methods and treatments for idiopathic pulmonary fibrosis (IPF), a serious lung condition.
Latest Patents
Noth's latest patents include innovative approaches to assessing and treating IPF. One of his notable patents is focused on biomarkers for assessing idiopathic pulmonary fibrosis. This patent discloses methods and kits for evaluating whether an individual with IPF has slowly or rapidly progressive disease. Another significant patent outlines a method for treating idiopathic pulmonary fibrosis using N-acetylcysteine (NAC). This method involves administering NAC to patients based on specific genetic markers identified through genotyping.
Career Highlights
Throughout his career, Imre Noth has worked with esteemed institutions such as the University of Chicago and the University of Pittsburgh. His research has been pivotal in advancing the understanding and treatment of pulmonary diseases.
Collaborations
Noth has collaborated with notable colleagues in his field, including Jose David Herazo-Maya and Naftali Kaminski. These collaborations have further enriched his research and contributions to pulmonary fibrosis.
Conclusion
Imre Noth's work in the field of pulmonary fibrosis has led to important advancements in both assessment and treatment options for patients. His innovative patents and collaborations highlight his commitment to improving healthcare outcomes for individuals affected by this challenging condition.